BGNE Nov 2024 180.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

33.85

0.00

(0.00%)

As of 12:20PM EDT. Market open.

Loading interactive chart...

Business Wire
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
SAN MATEO, Calif., May 14, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data from its hematology portfolio and pipeline at the European Hematology Association 2024 Hybrid Congress (EHA2024) in Madrid, Spain, June 13-16, 2024. BeiGene has 28 abstracts accepted at EHA2024, with four scheduled for oral presentations.
Simply Wall St.
The BeiGene, Ltd. (NASDAQ:BGNE) First-Quarter Results Are Out And Analysts Have Published New Forecasts
A week ago, BeiGene, Ltd. ( NASDAQ:BGNE ) came out with a strong set of quarterly numbers that could potentially lead...
Simply Wall St.
BeiGene First Quarter 2024 Earnings: Beats Expectations
BeiGene ( NASDAQ:BGNE ) First Quarter 2024 Results Key Financial Results Revenue: US$751.7m (up 68% from 1Q 2023). Net...